Literature DB >> 12138904

Successful treatment of progressive NK cell lymphoma with allogeneic peripheral stem cell transplantation followed by early cyclosporine tapering and donor leukocyte infusions.

Masanori Makita1, Yoshinobu Maeda, Katsuto Takenaka, Katsuji Shinagawa, Kazutaka Sunami, Yasushi Hiramatsu, Nobuharu Fujii, Fumihiko Ishimaru, Kazuma Ikeda, Kenji Niiya, Tadashi Yoshino, Mine Harada.   

Abstract

We describe a patient with progressive natural killer (NK) cell lymphoma who was treated successfully with allogeneic peripheral blood stem cell transplantation (allo-PBSCT) followed by early cyclosporine (CsA) tapering and donor leukocyte infusion (DLI). Because the disease showed early resistance to conventional chemoradiotherapy, we performed high-dose chemotherapy followed by allo-PBSCT. After achieving hematologic engraftment, the patient underwent early tapering of CsA and DLI in an attempt to induce a graft-versus-lymphoma effect. Although the disease was in a progressive state at the time of transplantation, complete remission was obtained after allo-PBSCT. As of this report, the patient has been well for more than 2 years.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12138904     DOI： 10.1007/bf02982726

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  16 in total

1.  G-CSF-induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantation.

Authors:  M Harada; K Nagafuji; T Fujisaki; A Kubota; S Mizuno; K Takenaka; T Miyamoto; Y Ohno; H Gondo; M Kuroiwa; T Okamura; S Inaba; Y Niho
Journal:  J Hematother       Date:  1996-02

2.  Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease.

Authors:  M de Lima; M Bonamino; Z Vasconcelos; M Colares; H Diamond; I Zalcberg; R Tavares; D Lerner; R Byington; L Bouzas; J da Matta; C Andrade; L Carvalho; V Pires; B Barone; C Maciel; D Tabak
Journal:  Bone Marrow Transplant       Date:  2001-01       Impact factor: 5.483

3.  Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia.

Authors:  S Carlens; J Aschan; M Remberger; M Dilber; O Ringdén
Journal:  Bone Marrow Transplant       Date:  1999-09       Impact factor: 5.483

4.  Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning.

Authors:  Y Oji; Y Oka; T Tatekawa; T Soma; T Matsunashi; T Yamagami; A Tsuboi; H Tamaki; E H Kim; H Sugiyama; H Ogawa
Journal:  Int J Hematol       Date:  1999-06       Impact factor: 2.490

5.  Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation.

Authors:  Y Nawa; K Takenaka; K Shinagawa; S Deguchi; N Matsumura; S Koyama; Y Hiramatsu; E Omoto; T Yoshino; M Harada
Journal:  Bone Marrow Transplant       Date:  1999-06       Impact factor: 5.483

6.  Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.

Authors:  M de Lima; K W van Besien; S A Giralt; I F Khouri; R Mehra; B S Andersson; D Przepiorka; J L Gajewski; M Korbling; R E Champlin
Journal:  Bone Marrow Transplant       Date:  1997-01       Impact factor: 5.483

Review 7.  Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties.

Authors:  H J Kolb
Journal:  Vox Sang       Date:  1998       Impact factor: 2.144

8.  Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.

Authors:  E B Papadopoulos; M Ladanyi; D Emanuel; S Mackinnon; F Boulad; M H Carabasi; H Castro-Malaspina; B H Childs; A P Gillio; T N Small
Journal:  N Engl J Med       Date:  1994-04-28       Impact factor: 91.245

9.  Successful treatment of Epstein-Barr virus-associated natural killer cell large granular lymphocytic leukaemia using allogeneic peripheral blood stem cell transplantation.

Authors:  A Takami; S Nakao; A Yachie; Y Kasahara; H Okumura; Y Miura; N Sugimori; W Zeng; H Wang; T Kotani; S Shiobara; T Matsuda
Journal:  Bone Marrow Transplant       Date:  1998-06       Impact factor: 5.483

10.  Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease.

Authors:  S Mackinnon; E B Papadopoulos; M H Carabasi; L Reich; N H Collins; F Boulad; H Castro-Malaspina; B H Childs; A P Gillio; N A Kernan
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113
View more
  4 in total

1.  Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia.

Authors:  Shojiro Haji; Motoaki Shiratsuchi; Takamitsu Matsushima; Akiko Takamatsu; Mariko Tsuda; Yasuhiro Tsukamoto; Emi Tanaka; Hirofumi Ohno; Eriko Fujioka; Yuriko Ishikawa; Ken-Ichi Imadome; Yoshihiro Ogawa
Journal:  Int J Hematol       Date:  2016-11-09       Impact factor: 2.490

Review 2.  Hematopoietic stem cell transplantation in natural killer cell lymphoma and leukemia.

Authors:  Yok-Lam Kwong
Journal:  Int J Hematol       Date:  2010-11-25       Impact factor: 2.490

3.  Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK/T-cell lymphoma.

Authors:  Meng Li; Chunji Gao; Honghua Li; Zhihong Wang; Yongbin Cao; Wenrong Huang; Xiaohong Li; Shuhong Wang; Li Yu; Wanming Da
Journal:  Med Oncol       Date:  2010-04-23       Impact factor: 3.064

4.  Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation.

Authors:  Yasuo Mori; Takatoshi Aoki; Katsuto Takenaka; Takuji Yamauchi; Asataro Yamamoto; Kenjiro Kamezaki; Hiromi Iwasaki; Naoki Harada; Toshihiro Miyamoto; Koji Nagafuji; Takanori Teshima; Koichi Akashi
Journal:  Int J Hematol       Date:  2009-12-02       Impact factor: 2.490
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.